Every law firm that pursues aggressive growth eventually confronts the same uncomfortable tension between expanding its reach and protecting what made it worth growing in the first place. Scott Rahn, Founding Partner
A new study suggests artificial intelligence may already be influencing the written opinions of federal appellate courts across the United States. Attorney Josh Morrow ran approximately 2,250 published federal appellate opinions from
More
The Texas Stock Exchange has secured its first primary equity market listings, poaching companies directly from the New York Stock Exchange in a significant milestone for the upstart bourse. The development marks
More
OpenAI has delayed plans for what could be one of the largest technology stock market listings on record, with chief executive Sam Altman ruling out a public float in 2026. Altman told
More
Akeso and Summit Therapeutics (SMMT) have reported a significant breakthrough in the treatment of non-small cell lung cancer with their jointly developed drug ivonescimab. The bispecific antibody reduced the risk of death
More
The Department of Labor’s Employee Benefits Security Administration issued Field Assistance Bulletin No. 2026-03 on September 8, 2026, reshaping how it enforces mental health parity rules. The bulletin establishes a focused enforcement
More
The FTSE 100 last hit an all-time high on 27 February, closing at 10,910.55, and has failed to break that record for over six months. This represents the longest stall in more
More
Bank of America (BAC) has issued a significant warning to investors navigating an increasingly volatile and uncertain stock market environment in 2026. The Wall Street banking giant cautioned that equity markets face
More
Reform UK’s record £72m fundraising haul from two cryptocurrency billionaires could be clawed back under retrospective donation rules being pushed through parliament by the government. Housing Secretary Angela Rayner warned that new
More
Sanofi is turning to one of the fastest-growing sports in the country to drive awareness of its protein-based COVID-19 vaccine, Nuvaxovid. The French pharmaceutical giant has announced a partnership with USA Pickleball,
More
Utah Law Professor Amos Guiora Pushes To Criminalise Enablers Who Shield Abusers From Accountability
Amos Guiora, a law professor at the University of Utah’s S.J. Quinney College of Law, has built his career around a deceptively simple question: what happens to those who knew and did
More